Home > Quotes > STJ

St. Jude Medical, Inc. Stock Quote & Summary Data

STJ 
$45.15
*  
0.02
  negative  
0.04%
Get STJ Alerts
*Delayed - data as of May 24, 2013 
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    STJ After Hours
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.


Don't know the stock symbol? Use the symbol lookup tool.

Alphabetize the sort order of my symbols 
Symbol Lookup
Log in or Register
 Save stocks for next time
 | Sponsored

1 Year Target: 46
Today's High/Low:  / 
Share Volume:
90 Day Avg. Daily Volume This is the average share volume for the past 50 trading days, for NASDAQ stocks and 90 trading days for Non-NASDAQ stocks. This field allows you to compare today’s trading to the average daily volume. 2,825,085
Previous Close: $ 45.17
52 Week High /Low: $ 47.45 / $ 30.25
Market cap “Market Capitalization” is a measure of the estimated value of the common equity securities of the company or their equivalent. It does not include securities convertible into the common equity securities. “Market Capitalization” is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable). NASDAQ does not use this value to determine compliance with the listing requirements. 12,793,827,305
P/E Ratio: 17.99
Forward P/E(1y) A widely used stock evaluation measure. For a security, the Price/Earnings Ratio is given by dividing the Last Sale Price by the Average EPS (Earnings Per Share) Estimate for the specified fiscal time period. The forward P/E refers to the value for the next full year. 12.21
Earnings Per Share (EPS) The EPS listed on our infoquote and Summary Quote page is "12-mos Rolling". EPS represents the portion of a company's profit allocated to each outstanding share of common stock. Net income (reported or estimated) for a period of time is divided by the total number of shares outstanding (TSO) during that period; See growth rate measures for EPS. Our vendor's methodology for the EPS on the infoquote and Summary Quote pages follows the EPS used by the majority of the analysts following the stock, in many cases this is EBITDA EPS. $ 2.51
Annualized dividend $ 1
Ex Dividend Date Mar. 26, 2013
Dividend Payment Date Apr. 30, 2013
Current Yield 2.21 %
Beta 1.08

 Intraday Chart

5d | 1m | 6m | 12m | More Charting

ETFs with STJ as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
5.6% Market Vectors Wide Moat ETF (MOAT) +2.74  (13.08%)
4.69% iShares Dow Jones U.S. Medical Devices Index Fund (IHI) +12.54  (18.82%)
2.63% SPDR S&P Health Care Equipment (XHE) +5.37  (9.51%)
2.6% PowerShares Dynamic Heathcare (PTH) +3.18  (9.36%)
2.01% Guggenheim S&P 500 Equal Weight Healthcare ETF (RYH) +17.65  (22.65%)

We make it easy to follow the leaders. PowerShares QQQ. 100 companies at the top of innovation in one fund.


*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.

**Green highlights the top performing ETF by % change in the past 100 days.

 Company Description (as filed with the SEC)

St. Jude Medical, Inc. develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas and neurostimulation medical devices for the management of chronic pain. Our principal products in each therapy area are as follows: Cardiac Rhythm Management – tachycardia implantable cardioverter defibrillator systems (ICDs) and bradycardia pacemaker systems (pacemakers); Cardiovascular – vascular products, which include vascular closure products, pressure measurement guidewires, optical coherence tomography (OCT) imaging products, vascular plugs and other vascular accessories, and structural heart products, which include heart valve replacement and repair products and structural heart defect devices; Atrial Fibrillation – electrophysiology (EP) introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems; and Neuromodulation – neurostimulati  ... More ...  



News Headlines for STJ

St. Jude Begins EnligHTNment Study - Analyst Blog
5/24/2013 3:28:35 PM - Zacks.com
Johnson & Johnson: At The Crossroads - Part IV - One Road To Higher Profit Growth Rates
5/23/2013 6:30:00 AM - Seeking Alpha
One Year Data from St. Jude Medical Study Demonstrates Safe, Rapid and Sustained Blood Pressure Reduction with EnligHTN Renal Denervation Technology
5/23/2013 4:15:00 AM - Business Wire
St. Jude Medical EnligHTNment Study Highlighted at EuroPCR During Trials That May Change Clinical Practice Session
5/21/2013 9:52:00 AM - Business Wire
St. Jude Medical to Present at the 38th Annual Deutsche Bank Health Care Conference
5/21/2013 8:00:00 AM - Business Wire
 

Consensus Recommendation